165 related articles for article (PubMed ID: 21671910)
1. Scleromyxedema with monoclonal gammopathy and neurological involvement: recovery from coma after plasmapheresis?
do Prado AD; Schmoeller D; Bisi MC; Piovesan DM; Dias FS; Staub HL
Int J Dermatol; 2012 Aug; 51(8):1013-5. PubMed ID: 21671910
[No Abstract] [Full Text] [Related]
2. [Response to thalidomide in scleromyxedema].
Pascualini MF; Caballero Escuti G; Valente E; Kurpis M; Ruiz Lascano A
Medicina (B Aires); 2013; 73(3):252-4. PubMed ID: 23732202
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of scleromyxedema with oral thalidomide.
Guarenti I; Sebastiani V; Pinto G; de Souza PR; de Almeida H
Int J Dermatol; 2013 May; 52(5):631-2. PubMed ID: 23231733
[No Abstract] [Full Text] [Related]
4. Plasma cell-directed therapies in monoclonal gammopathy-associated scleromyxedema.
Mahévas T; Arnulf B; Bouaziz JD; Livideanu CB; Osio A; Servy A; Cribier B; Sassolas B; Jachiet M; Michel L; Aucouturier P; Lipsker D; Frances C; Sbidian E; Rybojad M; Descamps V; D'Incan M; Humbert P; Beylot-Barry M; Passeron T; de Moreuil C; Taha RY; Hermine O; Dupuy A; Barbarot S; Debarbieux S; Carpentier O; Brault F; Schmutz JL; Thomas-Beaulieu D; Modiano P; Zarnitsky C; Lifermann F; Baubion E; Limal N; Le Bras F; Le Moigne M; Tauber M; Talbot A; Prud'homme R; Peltier S; De Masson A; Battistella M; Bagot M; Mékinian A; Fain O
Blood; 2020 Apr; 135(14):1101-1110. PubMed ID: 32027747
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of patients with monoclonal Ig deposition disease treated with high-dose melphalan and stem cell transplantation.
Girnius S; Seldin DC; Quillen K; Dember LM; Segal A; Sanchorawala V
Bone Marrow Transplant; 2011 Jan; 46(1):161-2. PubMed ID: 20383204
[No Abstract] [Full Text] [Related]
6. Scleromyxedema.
Heymann WR
J Am Acad Dermatol; 2007 Nov; 57(5):890-1. PubMed ID: 17939940
[No Abstract] [Full Text] [Related]
7. Successful treatment of scleromyxedema with melphalan and dexamethasone followed by thalidomide maintenance therapy.
Cao XX; Wang T; Liu YH; Zhou DB; Li J
Leuk Lymphoma; 2016 Dec; 57(12):2934-2936. PubMed ID: 27118492
[No Abstract] [Full Text] [Related]
8. sQUIZ your knowledge: Widespread millimetric papules in a patient with monoclonal gammopathy.
Iglesias-Puzas Á; Rodríguez-Jato Q; Flórez Á
Eur J Dermatol; 2019 Apr; 29(2):244-245. PubMed ID: 31106768
[No Abstract] [Full Text] [Related]
9. Managing scleromyxedema with intravenous immunoglobulin: acute worsening of scleromyxedema with biclonal gammopathy.
Manousaridis I; Loeser C; Goerdt S; Hassel JC
Acta Dermatovenerol Alp Pannonica Adriat; 2010 Dec; 19(4):15-9. PubMed ID: 21390475
[TBL] [Abstract][Full Text] [Related]
10. Vincristine, idarubicin, dexamethasone and thalidomide in scleromyxoedema.
Laimer M; Namberger K; Massone C; Koller J; Emberger M; Pleyer L; Hintner H; Greil R
Acta Derm Venereol; 2009 Nov; 89(6):631-5. PubMed ID: 19997697
[TBL] [Abstract][Full Text] [Related]
11. Thalidomide and dexamethasone followed by autologous stem cell transplantation for scleromyxoedema.
Bos R; de Waal EG; Kuiper H; Hazenberg BP; Vellenga E
Rheumatology (Oxford); 2011 Oct; 50(10):1925-6. PubMed ID: 21719421
[No Abstract] [Full Text] [Related]
12. Scleromyxedema without paraproteinemia.
Abarzúa AA; Giesen LF; Sandoval MO; González SB
Int J Dermatol; 2014 Aug; 53(8):971-4. PubMed ID: 24527753
[TBL] [Abstract][Full Text] [Related]
13. [Dermato-neuro syndrome during scleromyxedema: efficacy of plasmapheresis and intravenous immunoglobulin].
Charles S; Hainaut E; Cante V; Valette C; Levillain P; Guillet G
Ann Dermatol Venereol; 2014; 141(8-9):523-7. PubMed ID: 25209816
[TBL] [Abstract][Full Text] [Related]
14. Myeloablative immunosuppressive treatment with autologous haematopoietic stem cell transplantation in a patient with psoriatic arthropathy and monoclonal gammopathy of undetermined significance.
Mohren M; Daikeler T; Benz D; Günaydin I; Kanz L; Kötter I
Ann Rheum Dis; 2004 Apr; 63(4):466-7. PubMed ID: 15020351
[No Abstract] [Full Text] [Related]
15. [Plasmapheresis: an effective procedure for paraproteinemia coma].
Blank HJ; Brinkmann OH; Junge-Hülsing G
Dtsch Med Wochenschr; 1980 Oct; 105(40):1396. PubMed ID: 7449637
[No Abstract] [Full Text] [Related]
16. Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients.
Sansbury JC; Cocuroccia B; Jorizzo JL; Gubinelli E; Gisondi P; Girolomoni G
J Am Acad Dermatol; 2004 Jul; 51(1):126-31. PubMed ID: 15243538
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic stem cell transplantation for the treatment of refractory scleromyxedema.
Shayegi N; Alakel N; Middeke JM; Schetelig J; Mantovani-Löffler L; Bornhäuser M
Transl Res; 2015 Feb; 165(2):321-4. PubMed ID: 24999269
[TBL] [Abstract][Full Text] [Related]
18. A rare complication of monoclonal gammopathy.
Nasr SH; Lobritto SJ; Lauring BP; Arend LJ; D'Agati VD; Markowitz GS
Am J Kidney Dis; 2002 Oct; 40(4):867-71. PubMed ID: 12324928
[No Abstract] [Full Text] [Related]
19. Scleromyxedema--thalidomide therapy.
Martins A; Paiva Lopes MJ; Tavares Belo R; Rodrigues JC
J Eur Acad Dermatol Venereol; 2008 May; 22(5):622-4. PubMed ID: 18312333
[No Abstract] [Full Text] [Related]
20. Case of erythema elevatum diutinum associated with IgA paraproteinemia successfully controlled with thalidomide and plasma exchange.
Manni E; Cervadoro E; Papineschi F
Ther Apher Dial; 2015 Apr; 19(2):195-6. PubMed ID: 25257541
[No Abstract] [Full Text] [Related]
[Next] [New Search]
